🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The great saphenous vein is the most commonly used material in coronary vas...
Status
Completed
Location
Changhai Hospital
Start Date
2013-12
Trial ID
NCT02010996
Treatments Being Tested
The purpose of this study is to determine if the combination of thoracic pa...
Status
Completed
Location
The Ottawa Hospital
Start Date
2009-09
Trial ID
NCT01089933
Treatments Being Tested
Over the past few years, several studies have been made on various outcomes...
Status
Completed
Location
National Cancer Center
Start Date
2012-05
Trial ID
NCT01969253
Breast surgery plays an important role in the treatment of breast cancer. T...
Status
Unknown
Location
University hospital of Linkoping
Start Date
2021-01-21
Trial ID
NCT05901064
Treatments Being Tested
Axillary lymphadenectomy in breast cancer continues to be a common practice...
Status
Recruiting
Location
Maresme health consortium
Start Date
2022-04-01
Trial ID
NCT05280353
Treatments Being Tested
Patients with biopsy proven breast cancer, clinical stage I and II, will be...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
1979-09-04
Trial ID
NCT01468883
In this study, we compared a negative pressure wound therapy, versus a conv...
Status
Unknown
Location
CHRU
Start Date
2014-01-01
Trial ID
NCT04583605
Treatments Being Tested
The goal of this clinical trial is to learn how to successfully introduce a...
Status
Recruiting
Location
Noordwest Ziekenhuisgroep
Start Date
2025-04-18
Trial ID
NCT07146295
Treatments Being Tested
RATIONALE: Surgery to remove axillary lymph nodes may be an effective treat...
Status
Completed
Location
Istituto Nazionale per lo Studio e la Cura dei Tumori
Start Date
1995-12
Trial ID
NCT00002720
Treatments Being Tested
A total of 93 suitable patients will be randomly allocated into three group...
Status
Unknown
Location
Hany Mohamed Elgohary
Start Date
2023-04-15
Trial ID
NCT05920369